The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Open accessAbstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder to date. Neuropathological hallmarks are β-amyloid (A β) plaques and neurofibrillary tangles, but the inflammatory process has a fundamental role in the pathogenesis of AD. Inflammatory components related to AD neuroinflammation include brain cells such as microglia and astrocytes, the complement system, as well as cytokines and chemokines. Cytokines play a key role in inflammatory and anti-inflammatory processes in AD. An important factor in the onset of inflammatory process is the overexpression of interleukin (IL)-1, which produces many reactions in a vicious circle that cause dysfunction and neuronal death. Other important cytokines in neuroinflammation are IL-6 and tumor necrosis factor (TNF)-α. By contrast, other cytokines such as IL-1 receptor antagonist (IL-1ra), IL-4, IL-10, and transforming growth factor (TGF)-β can suppress both proinflammatory cytokine production and their action, subsequently protecting the brain. It has been observed in epidemiological studies that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) decreases the risk for developing AD. Unfortunately, clinical trials of NSAIDs in AD patients have not been very fruitful. Proinflammatory responses may be countered through polyphenols. Supplementation of these natural compounds may provide a new therapeutic line of approach to this brain disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Kingsley, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.2.133 · Cited by 1,933
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 1×
“This activation is thought to result from the glial reaction to the events related to the ongoing deposition of Aβ [16–18].”
BackgroundA subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“ibuprofen, indomethacin, and sulindac sulphide were shown to decrease the Aβ-42 peptide by up to 80% in cultured cells (effect not observed with naproxen, celecoxib, or aspirin) [183].”
BackgroundSteinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“Conflict of Interests Authors declare no competing financial interests.”
BackgroundWyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944
Overview of Dietary Flavonoids: Nomenclature, Occurrence and Intake
Beecher, G. R. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.10.3248s · Cited by 909
Apoptosis and Caspases in Neurodegenerative Diseases
Friedlander, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022366 · Cited by 873
Raivich, G., Bohatschek, M., Kloss, C. U. A., Werner, A., Jones, L. L., & Kreutzberg, G. W. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00007-7 · Cited by 844
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. C., & Brosnan, C. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 825
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
Gérard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.547 · Cited by 796
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Cytokines and the nervous system I: expression and recognition
Hopkins, S. J., & Rothwell, N. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80029-2 · Cited by 751
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., Piccoli, D. S., & Hamilton, J. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3803 · Cited by 742
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 708
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Intake of flavonoids and risk of dementia
Commenges, D., Scotet, V., Renaud, S., Jacqmin-Gadda, H., Barberger-Gateau, P., & Dartigues, J.-F. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 634
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
Interleukin 1 signaling occurs exclusively via the type I receptor.
Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., & Shanebeck, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6155 · Cited by 611
Carter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 601
Microglia in degenerative neurological disease
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 596
Glia and their cytokines in progression of neurodegeneration
Mrak, R. E., & Griffin, W. S. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.010 · Cited by 592
Selkoe, D. J., Podlisny, M. B., Joachim, C. L., Vickers, E. A., Lee, G., Fritz, L. C., & Oltersdorf, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7341 · Cited by 583
Woodroofe, M. N., Sarna, G. S., Wadhwa, M., Hayes, G. M., Loughlin, A. J., Tinker, A., & Cuzner, M. L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90110-s · Cited by 580
β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury
Gentleman, S. M., Nash, M. J., Sweeting, C. J., Graham, D. I., & Roberts, G. W. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90398-5 · Cited by 566
Complement: a unique innate immune sensor for danger signals
GASQUE, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.011 · Cited by 552
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
Relton, J. K., & Rothwell, N. J. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90033-t · Cited by 546
Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S., & Brosnan, C. F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.129 · Cited by 544
Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533
Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511
Fahnestock, M., Michalski, B., Xu, B., & Coughlin, M. D. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1016 · Cited by 490
Radical Scavenging by Flavonoid Antioxidants
Bors, W., & Saran, M. (1987) · Free Radical Research Communications · doi:10.3109/10715768709065294 · Cited by 478
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469
A randomized controlled trial of prednisone in Alzheimer’s disease
Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464
Distinct functions of COX-1 and COX-2
Morita, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00029-1 · Cited by 462
Inflammatory Neurodegeneration Mediated by Nitric Oxide, Glutamate, and Mitochondria
Brown, G. C., & Bal-Price, A. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:325 · Cited by 461
The microglial "activation" continuum: from innate to adaptive responses
Town, T., Nikolic, V., & Tan, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-24 · Cited by 456
Serum insulin-like growth factor I regulates brain amyloid-β levels
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002) · Nature Medicine · doi:10.1038/nm793 · Cited by 448
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
Serum insulin-like growth factor I regulates brain amyloid-β levels
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002) · Nature Medicine · doi:10.1038/nm1202-793 · Cited by 440
Fukumura, D., Xu, L., Chen, Y., Gohongi, T., Seed, B., & Jain, R. K. (2001) · PubMed · Cited by 440
Du Yan, S., Zhu, H., Fu, J., Yan, S. F., Roher, A., Tourtellotte, W. W., Rajavashisth, T., Chen, X., Godman, G. C., Stern, D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 428
Glial cytokines in Alzheimer's disease: Review and pathogenic implications
Mrak, R. E., Sheng, J. G., & Griffin, W. S. T. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90001-2 · Cited by 418
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Strle, K., Zhou, J.-H., Shen, W.-H., Broussard, S. R., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2001) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v21.i5.20 · Cited by 400
Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L., & Gold, L. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1500 · Cited by 386
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P. A., & Yen, S. H. (1988) · PubMed · Cited by 385
Rofecoxib: No effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B. A., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 385
A randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 384
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Joseph, J. A., Arendash, G., Gordon, M., Diamond, D., Shukitt-Hale, B., Morgan, D., & Denisova, N. A. (2003) · Nutritional Neuroscience · doi:10.1080/1028415031000111282 · Cited by 362
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360
Interleukin-1, neuroinflammation, and Alzheimer's disease
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00287-1 · Cited by 356
Functions of IL-4 and Control of Its Expression
Brown, M. A., & Hural, J. (2017) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v37.i2-6.30 · Cited by 354
The role of amyloid β peptide 42 in Alzheimer's disease
Findeis, M. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.006 · Cited by 324
Maier, M., Peng, Y., Jiang, L., Seabrook, T. J., Carroll, M. C., & Lemere, C. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0829-08.2008 · Cited by 323
Olson, L., Nordberg, A., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02257624 · Cited by 323
Role of complement in neurodegeneration and neuroinflammation
BONIFATI, D., & KISHORE, U. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.007 · Cited by 313
Cytokines and the nervous system I: expression and recognition
HOPKINS, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93881-w · Cited by 306
Misonou, H., Morishima-Kawashima, M., & Ihara, Y. (2000) · Biochemistry · doi:10.1021/bi000169p · Cited by 304
Functions of IL-4 and Control of Its Expression
Brown, M. A., & Hural, J. (1997) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v17.i1.10 · Cited by 302
The role of TNF and its receptors in Alzheimer's disease
Perry, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00291-3 · Cited by 297
Marchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240524 · Cited by 294
Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
Inflammatory mechanisms in Alzheimer's disease
Eikelenboom, P., Zhan, S.-S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291
An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003
Wimo, A., Jonsson, L., & Winblad, B. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090733 · Cited by 289
Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.
Vodovotz, Y., Lucia, M. S., Flanders, K. C., Chesler, L., Xie, Q. W., Smith, T. W., Weidner, J., Mumford, R., Webber, R., Nathan, C., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1425 · Cited by 288
Chemokine and chemokine receptor expression in the central nervous system
Hesselgesser, J., & Horuk, R. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029741 · Cited by 284
BLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease
Xia, M., & Hyman, B. T. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029743 · Cited by 269
Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia
Botchkina, G. I., Meistrell, M. E., Botchkina, I. L., & Tracey, K. J. (1997) · Molecular Medicine · doi:10.1007/bf03401714 · Cited by 265
Acute and Chronic Inflammation
Klatt, E. C., & Kumar, V. (2010) · Robbins and Cotran Review of Pathology · doi:10.1016/b978-1-4160-4930-2.00002-5 · Cited by 252
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01389-x · Cited by 251
Griffin, W. S. T., & Mrak, R. E. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.2.233 · Cited by 248
Cytokines in Neuroinflammation and Alzheimers Disease
Cacquevel, M., Lebeurrier, N., Cheenne, S., & Vivien, D. (2004) · Current Drug Targets · doi:10.2174/1389450043345308 · Cited by 245
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
Ho, L., Pieroni, C., Winger, D., Purohit, D. P., Aisen, P. S., & Pasinetti, G. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990801)57:3<295::aid-jnr1>3.0.co;2-0 · Cited by 244
Szczepanik, A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00404-5 · Cited by 243
Gasque, P., Fontaine, M., & Morgan, B. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4726 · Cited by 241
Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease
Perlmutter, L. S., Barron, E., & Chui, H. C. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90748-x · Cited by 240
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231 · cited 1×
“An epidemiological study of Dutch adults, for example, found that total dietary flavonoid intake was not associated with the risk of developing AD [212, 213].”
BackgroundTransforming growth factor-β1 is in plaques in Alzheimer and Down pathologies
van der Wal, E. A., Gómez-Pinilla, F., & Cotman, C. W. (1993) · NeuroReport · doi:10.1097/00001756-199301000-00018 · Cited by 231
Expression of complement in the brain: role in health and disease
Morgan, B. P., & Gasque, P. (1996) · Immunology Today · doi:10.1016/0167-5699(96)20028-f · Cited by 230
Breder, C. D., Tsujimoto, M., Terano, Y., Scott, D. W., & Saper, C. B. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903370403 · Cited by 226
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Permanne, B., Adessi, C., Saborio, G. P., Fraga, S., Frossard, M., Van Dorpe, J., Dewachter, I., Banks, W. A., Van Leuven, F., & Soto, C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0841fje · Cited by 220
The microglial phagocytic role with specific plaque types in the Alzheimer disease brain
D’Andrea, M. R., Cole, G. M., & Ard, M. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.026 · Cited by 215
Neuroprotective role of IL-4 against activated microglia.
Chao, C. C., Molitor, T. W., & Hu, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1473 · Cited by 213
Goyarzu, P., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., Moy, E., Moy, D., Lippold, S., Shukitt-Hale, B., et al. (2004) · Nutritional Neuroscience · doi:10.1080/10284150410001710410 · Cited by 213
Obregon, D. F., Rezai-Zadeh, K., Bai, Y., Sun, N., Hou, H., Ehrhart, J., Zeng, J., Mori, T., Arendash, G. W., Shytle, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600617200 · Cited by 209
Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms
Halliday, G., Robinson, S. R., Shepherd, C., & Kril, J. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03200.x · Cited by 208
Natarajan, C., & Bright, J. J. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363832 · Cited by 208
Complement Biosynthesis in the Central Nervous System
Barnum, S. R. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060020301 · Cited by 207
Joyce, D. A., Gibbons, D. P., Green, P., Steer, J. H., Feldmann, M., & Brennan, F. M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241119 · Cited by 206
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M. G., & Forloni, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11384-9 · Cited by 205
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
Aisen, P. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00133-3 · Cited by 203
Heneka, M. T., Löschmann, P., Gleichmann, M., Weller, M., Schulz, J. B., Wüllner, U., & Klockgether, T. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010088.x · Cited by 199
Mechanisms of Cell Signaling and Inflammation in Alzheimers Disease
Ho, G., Drego, R., Hakimian, E., & Masliah, E. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053586237 · Cited by 199
Sheng, J. G., Boop, F. A., Mrak, R. E., & Griffin, W. S. T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051872.x · Cited by 198
Bohlson, S. S., Fraser, D. A., & Tenner, A. J. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.021 · Cited by 198
Brain Aging and Midlife Tofu Consumption
White, L. R., Petrovitch, H., Ross, G. W., Masaki, K., Hardman, J., Nelson, J., Davis, D., & Markesbery, W. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718923 · Cited by 198
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Ledeboer, A., Brevé, J. J. P., Wierinckx, A., Van Der Jagt, S., Bristow, A. F., Leysen, J. E., Tilders, F. J. H., & Van Dam, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02200.x · Cited by 190
Chemokines and chemokine receptors in CNS pathology
Glabinski, A. R., & Ransohoff, R. M. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029740 · Cited by 184
The Seminal Role of β-Amyloid in the Pathogenesis of Alzheimer Disease
Joachim, C. L., & Selkoe, D. J. (1992) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199205000-00003 · Cited by 182
Neuroinflammatory perspectives on the two faces of Alzheimer?s disease
Eikelenboom, P., & van Gool, W. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0055-1 · Cited by 182
Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Finch, C., & Morgan, T. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362254 · Cited by 180
Interleukin-6 is the Major Regulator of Acute Phase Protein Synthesis in Rat and Man
CASTELL, J. V., DAVID, M., KLAPPROTH, J., HEINRICH, P. C., ANDUS, T., GEIGER, T., GÓMEZ-LECHÓN, M., HIRANO, T., & KISHIMOTO, T. (1989) · Advances in Immunopharmacology · doi:10.1016/b978-0-08-036149-9.50026-9 · Cited by 177
Kim, J. S., & Jobin, C. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02156.x · Cited by 173
The Role of Complement in Danger Sensing and Transmission
Kohl, J. (2006) · Immunologic Research · doi:10.1385/ir:34:2:157 · Cited by 172
Liu, J., Zhao, M. L., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170
Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Zheng, L. T., Ock, J., Kwon, B.-M., & Suk, K. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.12.012 · Cited by 169
Brain Under Surveillance: The Microglia Patrol
Fetler, L., & Amigorena, S. (2005) · Science · doi:10.1126/science.1114852 · Cited by 168
Frenkel, D., Maron, R., Burt, D. S., & Weiner, H. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23241 · Cited by 167
Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
Nataf, S., Stahel, P. F., Davoust, N., & Barnum, S. R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01390-3 · Cited by 167
Clarke, C. J. P., Hales, A., Hunt, A., & Foxwell, B. M. J. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1719::aid-immu1719>3.0.co;2-q · Cited by 164
Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme
Roßner, S., Lange‐Dohna, C., Zeitschel, U., & Perez‐Polo, J. R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02857.x · Cited by 163
Immunotherapy for Alzheimer's disease
Gélinas, D. S., Silva, K. D., Fenili, D., George‐Hyslop, P. S., & McLaurin, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404866101 · Cited by 162
Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161
TGF-β: A Critical Modulator of Immune Cell Function
Letterio, J. J., & Roberts, A. B. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4409 · Cited by 154
Increased CSF cortisol in AD is a function of APOE genotype
Peskind, E. R., Wilkinson, C. W., Petrie, E. C., Schellenberg, G. D., & Raskind, M. A. (2001) · Neurology · doi:10.1212/wnl.56.8.1094 · Cited by 154
Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia
Ferrari, E., Arcaini, A., Gornati, R., Pelanconi, L., Cravello, L., Fioravanti, M., Solerte, S. B., & Magri, F. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00160-1 · Cited by 153
Xu, Z., Chen, S., Li, X., Luo, G., Li, L., & Le, W. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9166-z · Cited by 152
Thornton, P., Pinteaux, E., Gibson, R. M., Allan, S. M., & Rothwell, N. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03872.x · Cited by 152
β‐Amyloid Precursor Protein Isoforms in Various Rat Brain Regions and During Brain Development
Löffler, J., & Huber, G. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08443.x · Cited by 150
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
O’Barr, S. A., Caguioa, J., Gruol, D. L., Perkins, G. A., Ember, J. A., Hugli, T. E., & Cooper, N. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4154 · Cited by 149
Heneka, M. T., Wiesinger, H., Dumitrescu‐Ozimek, L., Riederer, P. F., Feinstein, D. L., & Klockgether, T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.906 · Cited by 148
Ringheim, G. E., Szczepanik, A. M., Petko, W. W., Burgher, K. L., Zhu, S. Z., & Chao, C. C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00356-2 · Cited by 144
Braak, H., Braak, E., & Strothjohann, M. H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90589-4 · Cited by 143
Interleukin‐6: The Major Regulator of Acute‐Phase Protein Synthesis in Man and Rat
Castell, J. V., Andus, T., KUNZ, D., & Heinrich, P. C. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24001.x · Cited by 136
Cytokine and chemokine inter-regulation in the inflamed or injured CNS.
Owens, T., Babcock, A., Millward, J., & Toft-hansen, H. (2005) · Brain research. Brain research reviews · doi:10.1016/j.brainresrev.2004.12.007 · Cited by 134
Synergistic Induction of Nitric Oxide by β-Amyloid and Cytokines in Astrocytes
Rossi, F., & Bianchini, E. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1197 · Cited by 133
Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Strategies
Aisen, P. S. S. (2009) · Gerontology · doi:10.1159/000213842 · Cited by 130
The nerve growth factor: Thirty-five years later
Levi‐Montalcini, R. (1987) · Bioscience Reports · doi:10.1007/bf01116861 · Cited by 127
Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons
Murphy, P. G., Borthwick, L., Johnston, R. S., Kuchel, G. A., & Richardson, P. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03791.1999 · Cited by 126
Winter, C. D., Iannotti, F., Pringle, A. K., Trikkas, C., Clough, G. F., & Church, M. K. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00153-x · Cited by 122
Kang, T. H., Lee, J. H., Song, C. K., Han, H. D., Shin, B. C., Pai, S. I., Hung, C., Trimble, C. L., Lim, J., Kim, T. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2638 · Cited by 117
Lee, S. C., Zhao, M., Hirano, A., & Dickson, D. W. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199911000-00006 · Cited by 112
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 110
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P., & Breitner, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 102
Transforming growth factor beta in Alzheimer's disease
Chao, C. C., Hu, S., Frey, W. H., A, T., Tourtellotte, W. W., & Peterson, P. K. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.1.109-110.1994 · Cited by 102
Combs, C. K., Bates, P., Karlo, J. C., & Landreth, G. E. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00052-3 · Cited by 101
Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells
Plata‐Saláman, C. R., Ilyin, S. E., & Gayle, D. A. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.2.r566 · Cited by 99
Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells
Blasko, I., Apochal, A., Boeck, G., Hartmann, T., Grubeck‐Loebenstein, B., & Ransmayr, G. N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0451 · Cited by 94
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Yermakova, A., & O’Banion, M. K. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398672 · Cited by 93
Yin and Yang: complement activation and regulation in Alzheimer’s disease
Shen, Y., & Meri, S. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.08.001 · Cited by 92
Hammacher, A., Ward, L. D., Simpson, R. J., Weinstock, J., Treutlein, H., & Yasukawa, K. (1994) · Protein Science · doi:10.1002/pro.5560031213 · Cited by 91
Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice
Gong, C., Qin, Z., Betz, A. L., Liu, X.-H., & Yang, G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00489-2 · Cited by 90
Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4510 · Cited by 89
Franciosi, S., Choi, H. B., Kim, S. U., & McLarnon, J. G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.006 · Cited by 89
Dickensheets, H. L., Freeman, S. L., Smith, M. F., & Donnelly, R. P. (1997) · Blood · doi:10.1182/blood.v90.10.4162 · Cited by 87
Gianni, D., Zambrano, N., Bimonte, M., Minopoli, G., Mercken, L., Talamo, F., Scaloni, A., & Russo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211899200 · Cited by 87
Orzylowska, O., Oderfeld-Nowak, B., Zaremba, M., Januszewski, S., & Mossakowski, M. J. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00043-9 · Cited by 86
Serum cytokine levels in patients with Alzheimer's disease
Chao, C. C., A, T., Hu, S., Crossley, K., Sherman, R. E., Peterson, P. K., & Frey, W. H. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.4.433-436.1994 · Cited by 85
β-AMYLOID FRAGMENT POTENTIATES IL-6 AND TNF-α SECRETION BY LPS IN ASTROCYTES BUT NOT IN MICROGLIA
Forloni, G., Mangiarotti, F., Angeretti, N., Lucca, E., & Simoni, M. G. D. (1997) · Cytokine · doi:10.1006/cyto.1997.0232 · Cited by 84
Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
The possible role of complement activation in Alzheimer disease
McGeer, P. L., & McGeer, E. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02422-x · Cited by 81
Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s Disease
Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & Eikelenboom, P. (2003) · Current Drug Targets · doi:10.2174/1389450033490902 · Cited by 81
Hüll, M., Lieb, K. P., & Fiebich, B. L. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371292 · Cited by 80
Evaluation of the Anti-oxidative Effect (in vitro) of Tea Polyphenols
Hashimoto, F., Ono, M., Masuoka, C., Ito, Y., Sakata, Y., Shimizu, K., Nonaka, G., Nishioka, I., & Nohara, T. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.396 · Cited by 80
The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer’s disease
Mukherjee, P., & Pasinetti, G. M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00261-1 · Cited by 76
Wyss‐Coray, T., Lin, C., Euw, D. V., Masliah, E., Mucke, L., & Lacombe, P. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06382.x · Cited by 75
Transforming growth factor β and cancer
Nørgaard, P. H., Hougaard, S., Poulsen, H. S., & Spang‐Thomsen, M. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90038-1 · Cited by 73
Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum
Bénard, M., Raoult, É., Vaudry, D., Leprince, J., Falluel‐Morel, A., Gonzalez, B. J., Galas, L., Vaudry, H., & Fontaine, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.027 · Cited by 72
TNFα gene expression is induced in neurones after a hippocampal lesion
Tchélingérian, J., Vignais, L., & Jacque, C. (1994) · Neuroreport · doi:10.1097/00001756-199401000-00013 · Cited by 67
Ahn, H. Y., Xu, Y., & Davidge, S. T. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.018 · Cited by 65
Induction of interleukin-1 and interleukin-1 receptor antagonist.
Dinarello, C. (1997) · PubMed · Cited by 64
Szczepanik, A. M., & Ringheim, G. E. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5205 · Cited by 61
Chong, Y.-H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00936-3 · Cited by 60
Graham, D. I., Gentleman, S., Nicoll, J. A. R., Royston, M. C., McKenzie, J. E., Roberts, G. W., & Griffin, W. S. T. (1996) · Springer eBooks · doi:10.1007/978-3-7091-9465-2_17 · Cited by 59
Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist
Lundkvist, J., Sundgren‐Andersson, A. K., Tingsborg, S., Östlund, P., Engfors, C., Alheim, K., Bartfai, T., Iverfeldt, K., & Schultzberg, M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.3.r644 · Cited by 59
Veld, B. A. I., Launer, L. J., Breteler, M. M. B., Hofman, A., & Stricker, B. H. C. (2002) · Epidemiologic Reviews · doi:10.1093/epirev/mxf001 · Cited by 56
Cerebral neurons express interleukin-6 after transient forebrain ischemia in gerbils
Suzuki, S., Tanaka, K., Nagata, E., Ito, D., Dembo, T., & Fukuuchi, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00051-8 · Cited by 53
McGeer, E. G., & McGeer, P. L. (1997) · CNS Drugs · doi:10.2165/00023210-199707030-00005 · Cited by 53
Increased CSF levels of nerve growth factor in patients with Alzheimer’s disease
Hock, C., Heese, K., Müller-Spahn, F., Huber, P., Riesen, W., Nitsch, R. M., & Otten, U. (2000) · Neurology · doi:10.1212/wnl.54.10.2009 · Cited by 52
Transforming Growth Factor β2 Is a Neuronal Death-Inducing Ligand for Amyloid-β Precursor Protein
Hashimoto, Y., Chiba, T., Yamada, M., Nawa, M., Kanekura, K., Suzuki, H., Terashita, K., Aiso, S., Nishimoto, I., & Matsuoka, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9304-9317.2005 · Cited by 51
Cited by
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Association between periodontal pathogens and systemic disease
Bui, F. Q., Almeida-da-Silva, C. L. C., Huynh, B., Trinh, A., Liu, J., Woodward, J., Asadi, H., & Ojcius, D. M. (2019) · Biomedical Journal · doi:10.1016/j.bj.2018.12.001 · Cited by 829
Metadata
- Authors
- Rubio-Perez, J. M., & Morillas-Ruiz, J. M.
- Venue
- The Scientific World Journal
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-15
- ISSN
- 1537-744X (ISSN-L)
- OpenAlex
- W2080946103
- Cited by
- 839
- References
- 218
- FWCI
- 32.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.